| ||
| Morphotek and Biocare Partner to Develop mAb-Based Assay for Cancer Antigen Genetic Engineering News ... which is over-expressed on a number of cancers including pancreatic, ovarian, lung, and colorectal. The candidate is currently in Phase II development against pancreatic cancer, and in early clinical development against mesothelioma. ... See all stories on this topic » |
Tip: Use a plus sign (+) to match a term in your query exactly as is. Learn more.
Remove this alert.
Create another alert.
Manage your alerts.
No comments:
Post a Comment